Covered recipient · General Payments record
CARLA C COSTELLO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,436.02
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.13 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $45.86 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $33.77 | 2 |
| Merck Sharp & Dohme Corporation | $31.18 | 2 |
| Acerta Pharma LLC | $19.67 | 1 |
| Exact Sciences Corporation | $15.10 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $15.91 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000761 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.86 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000771 | CMS |
| Amgen Inc. | $15.74 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117532222 | CMS |
| Amgen Inc. | $14.82 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117532224 | CMS |
| Amgen Inc. | $15.30 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117532226 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.67 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104363455 | CMS |
| Exact Sciences Corporation | $15.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114432622 | CMS |
| Merck Sharp & Dohme LLC | $13.66 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141568543 | CMS |
| Merck Sharp & Dohme LLC | $17.52 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141568541 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.55 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144622252 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.